Skechers U.S.A., Inc. (SKX) — closed signal from August 17, 2025
Partial Published before the outcome was known, scored automatically when the window closed on November 15, 2025.
Predicted vs. what happened
What happened
Reached 4% of the predicted growth at its peak, without hitting the target.
The thesis — published August 17, 2025
The stock looks beaten down and may bounce back. On Aug 14, the owner of Kizik filed a patent lawsuit in Germany, adding uncertainty. That same day, a well-known value investor's firm bought 126k shares, showing confidence. On Aug 12, government data showed shoe prices rose 1.4% from the prior month, helping companies keep prices firm. If lawsuit headlines stay quiet, a 3-month recovery is possible, but news and shopper demand risks remain.
Primary drivers
- Shares look overly beaten down and may rebound in the near term
- Clear signs that large professional investors have been buying shares
- Rising shoe prices help profits by covering costs and lifting margins
- Patent lawsuit is a key risk; we will track headlines and updates closely
How it played out
SKX: the target was not reached
Lyra published SKX at 62.99 on 2025-08-17 with a short-term recovery thesis and expected growth of 16%. The thesis pointed to shares looking beaten down, large professional investor buying, firmer shoe prices, and the patent lawsuit as a risk that needed quiet headlines.
Inside the window from 2025-08-17 to 2025-11-15, SKX peaked at 63.37 on 2025-09-11. The peak gain was 0.6%, and the stock stayed below the 73.07 target. It ended at 63.13. The thesis did not play out in the measured window.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.